Cylindrospermopsin is a cyanobacterial toxin of increasing environmental importance, as it can lead to disease if orally or intravenously absorbed. However, its in vivo lung impairment has not been documented. Thus, we aimed at verifying whether cylindrospermopsin can induce lung injury and establish its putative dependence on the time elapsed since exposure.
Introduction
Cyanobacteria are a group of prokaryotic organisms primarily found in freshwater environments, especially in tropical regions, where warm water temperatures and high nutrient concentrations often allow their growth (Saker and Eaglesham, 1999) . Of major concern is the production of toxins that have become recognized as potent hazards in drinking water throughout the world (Falconer and Humpage, 2006) . Our previous studies with a cyanotoxin (Picanço et al., 2004; Soares et al., 2007; Carvalho et al., 2010; Casquilho et al., 2011) showed that a single intraperitoneal sub-lethal dose (40 mg/kg BW) of microcystin-LR (MCYST-LR) impairs lung mechanics and increases polymorphonuclear influx in lung parenchyma.
The toxic alkaloid cylindrospermopsin can be produced by a range of cyanobacterial species, like Cylindrospermopsis raciborskii (Ohtani et al., 1992) , Aphanizomenon ovalisporum (Banker et al., 1997) , Raphidiopsis curvata (Li et al., 2001) , and Umezakia natans . In 1978, a serious poisoning of humans resulting from consumption of water contaminated with the toxic cyanobacterium C. raciborskii took place in Palm Island, Australia. It was known as the "Palm Island mystery disease", and well over 100 children had to be admitted to the hospital showing various symptoms of gastroenteritis (Byth, 1980; Bourke et al., 1983; Griffiths and Saker, 2003; Berry et al., 2009) . Since that time a great deal of attention has been dedicated to cylindrospermopsin, although there is no data in the literature reporting the dose-dependence of human beings to that toxin. Poisoning resulted from recreation (Chorus et al., 2000; Rao et al., 2002) and possible accumulation in the food-web (Saker and Eaglesham, 1999) ; transmission from mice females to their fetuses (Paerl et al., 2001; Codd et al., 2005; Falconer and Humpage, 2006; Rogers et al., 2007) has also been reported.
Owing to its high solubility in water and low rate of bioand photodegradation, significant amounts of cylindrospermopsin can be expected to occur in the water column (Wormer et al., 2008 (Wormer et al., , 2010 . The toxin concentrations in the European environment were found to amount up to 12.1 mg/L in Germany (Rücker et al., 2007) , up to 9.4 mg/L in Spain (Quesada et al., 2006) , and up to 18.4 mg/L in Italy (Bogialli et al., 2006) . US EPA classified cylindrospermopsin as a compound with high priority for hazard characterization (U.S. Environmental Protection Agency, 2001).
Despite considerable research, much remains to be disclosed with respect to the toxicity of cylindrospermopsin. It is known that the toxin irreversibly inhibits protein synthesis. However, the mechanisms involved in its toxicity and metabolism are not well understood. Terao et al. (1994) reported ribosome detachment from the rough endoplasmic reticulum, and the linkage of an active metabolite of cylindrospermopsin to DNA or RNA, with consequent blockage of translation, was also suggested (Shaw et al., 2000) . Cylindrospermopsin can also induce DNA fragmentation, chromosome losses, and possibly carcinogenicity (Humpage et al., 2000 (Humpage et al., , 2005 Falconer and Humpage, 2001; Shen et al., 2002) . Cylindrospermopsin toxicity seems to present two toxic responses (Falconer, 2008) : The rapid toxicity appears to be mediated by CYP450 activation, which generates more toxic metabolites, while the longerterm toxicity is due to protein synthesis inhibition (Humpage et al., 2005) .
Although lethal doses of cylindrospermopsin can damage the liver, kidney, lung, heart, stomach and the vascular system (Hawkins et al., 1985) , there are no reports in the literature investigating in vivo pulmonary damage produced by sub-lethal doses of cylindrospermopsin. Moreover, the understanding of the effects of these doses of the toxin is relevant because human beings are often exposed to low doses of cyanotoxins. Hence, in the present study we aimed at verifying whether a single sub-lethal dose of cylindrospermopsin can induce lung injury, and establish its putative dependence on the time elapsed since exposure.
Materials and methods

Animals
BALB/c male mice (6-7 week of age) were purchased from CEMIB (Multidisciplinary Center for Biological Investigation, University of Campinas, Campinas, Brazil). The animals were housed in plastic cages with absorbent bedding material and maintained on a 12-h daylight cycle. Food and water were provided ad libitum. The experimental protocol was approved by the Ethics Committee on the Use of Animals, Health Sciences Center, Federal University of Rio de Janeiro (Protocol IBCCF 012).
Experimental procedures
Two separate experiments, with equal procedures, were necessary for this study. The first one used thirty-four mice, randomly divided into 6 groups (5-6 animals per group) for pulmonary mechanics and histological analyses. The second experiment had 30 animals sacrificed for all biochemical analyses.
We had 4 control animals at all time points in the first set of experiments. After running a one-way ANOVA followed by Bonferroni's multiple comparisons test using the mechanics data, all control groups were statistically similar. Thus, one animal was randomly picked up from each group and, thus, SAL group was formed (n ¼ 5). In the second batch of animals 5 mice were used as controls. SAL animals received a single intratracheal instillation (i.t.) of 50 mL of saline solution (NaCl 0.9%). Cylindrospermopsin groups (CYN) received a single sublethal dose of semi-purified extract of cylindrospermopsin (70 mg/kg body weight, i.e., 45-55 mL, i.t.). This dose was chosen based on the cylindrospermopsin LD 50 in mice (i.p.), namely, 200 mg/kg BW . All animals (25-30 g) were analyzed 2, 8, 24, 48 and 96 h after instillation. For intratracheal instillation mice were anesthetized with sevoflurane, and saline or cylindrospermopsin was gently instilled into their tracheas with the aid of an ultra-fine U-100 insulin syringe. The animals rapidly recovered after instillation.
All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the Academy of Sciences, USA.
Cylindrospermopsin semi-purified extract production
The animals were exposed to a semi-purified extract of C. raciborskii. The cylindrospermopsin producer strain CYP 011K, kindly provided by Dr. Andrew Humpage and Dr. Peter Baker (Australian Water Quality Centre, Adelaide, Australia) was cultured in ASM-1 medium, the lyophilized biomass was extracted in ultrapure water, centrifuged and passed through a C18 cartridge to remove part of the matrix interference. The process ensured the removal of any cyanobacterial LPS in the extract. The extraction step and HPLC analysis of toxin content were done according to Welker et al. (2002) .
Pulmonary mechanics
At 2, 8, 24, 48 and 96 h after instillation of saline or cylindrospermopsin the animals were sedated with diazepam (1 mg, i.p.), anesthetized with pentobarbital sodium (20 mg/kg BW, i.p.), tracheotomized, and a snugly fitting cannula (0.8 mm i.d.) was introduced into the trachea. The animals were then paralyzed with pancuronium bromide (0.1 mg/kg, i.v.) and mechanically ventilated with a constant-flow ventilator (Samay VR15, Universidad de la Republica, Montevideo, Uruguay) with respiratory frequency of 100 breaths/min, tidal volume of 0.2 mL, flow of 1 mL/s, and positive end-expiratory pressure of 2 cmH 2 O. The anterior chest wall was then surgically removed.
A pneumotachograph (15 mm i.d., length 4.2 cm, distance between side ports ¼ 2.1 cm) (Mortola and Novoraj, 1983) was connected to the tracheal cannula for the measurements of airflow (V 0 ). Lung volume (V T ) was measured by flow signal integration. The pressure gradient across the pneumotachograph was determined by means of a Valydine MP45-2 differential pressure transducer (Engineering Corp., Northridge, CA, USA). The flow resistance of the equipment (R eq ), tracheal cannula included, was constant up to flow rates of 26 mL/s and amounted to 0.12 cmH 2 OmL À1 s. Equipment resistive pressure (¼R eq $V 0 ) was subtracted from pulmonary resistive pressure so that the present results represent intrinsic values. Tracheal pressure was measured with a Validyne MP-45 differential pressure transducer (Engineering Corp. Northridge, CA, USA). All signals were conditioned and amplified in a Beckman type R Dynograph (Schiller Park, IL, USA). Flow and pressure signals were passed through 8-pole Bessel low-pass filters (902LPF, Frequency Devices, Haverhill, MA, USA) with the corner frequency set at 100 Hz, sampled at 200 Hz with a 12-bit analog-to-digital converter (DT2801A, Data Translation, Marlboro, MA, USA), and stored on a microcomputer. All data were collected using LABDAT software (RHT-InfoData Inc., Montreal, QC, Canada).
Lung resistive (DP1) and viscoelastic/inhomogeneous (DP2) pressures, total resistive pressure drop
, and viscoelastic component of elastance (DE) were measured by the endinflation occlusion method (Bates et al., 1985 (Bates et al., , 1988 . Briefly, after end-inspiratory occlusion, there is an initial fast drop in transpulmonary pressure (DP1) from the preocclusion value down to an inflection point (Pi) followed by a slow pressure decay (DP2), until a plateau is reached. This plateau corresponds to the elastic recoil pressure of the lung (Pel). DP1 selectively reflects airway resistance in normal animals and humans and DP2 reflects stress relaxation, or viscoelastic properties of the lung, together with a small contribution of time constant inequalities at the peripheral airspaces (Bates et al., 1988; Saldiva et al., 1992) . Lung static elastance (Est) was calculated by dividing Pel by tidal volume. DE was calculated as the difference between static and dynamic elastances and reflects the viscoelastic component of elastance (Bates et al., 1985 (Bates et al., , 1988 .
Histological study
Heparin (1000 IU) was intravenously injected immediately after the determination of pulmonary mechanics. The trachea was clamped at end-expiration and the abdominal aorta and vena cava were sectioned, yielding a massive hemorrhage that quickly euthanized the animals. To perform the morphometric study, the lungs were isolated at end-expiratory lung volume, quick-frozen by immersion in liquid nitrogen, and fixed with Carnoy's solution (ethanol:cloroform:acetic acid, 70:20:10) at À70 C. After 24 h, ethanol concentrations were progressively increased (70, 80, 90 and 100%, respectively, 1 h in each solution, at À20 C). The lungs were then kept in 100% ethanol for 24 h at 4 C (Nagase et al., 1992) . After fixation, tissue blocks were embedded in paraffin and 3-mm thick slices were cut, mounted, and stained with hematoxylin-eosin. Two investigators, who were unaware of the origin of the encoded material, examined the samples microscopically.
Morphometric analysis was performed with an integrating eyepiece with a coherent system made of a 100-point and 50-lines (known length) grid coupled to a conventional light microscope (Axioplan, Zeiss, Oberkochen, Germany). The fraction areas of collapsed and normal alveoli were determined by the point-counting technique at a magnification of Â200 across 10 random non-coincident microscopic fields per animal. Points falling on normal or collapsed alveoli were expressed as percentage of total points of the grid (Weibel et al., 1966; Gundersen et al., 1988) . Polymorpho-(PMN) and mononuclear (MN) cells, and pulmonary tissue were evaluated at Â1000 magnification across 10 random non-coincident microscopic fields in each animal (total area of 10,000 mm 2 /field). Points falling on pulmonary tissue were counted to determine lung tissue area in each field. PMN and MN cells were counted, and represented by total number of cells per area of lung tissue (Gundersen et al., 1988 ).
Biochemical analyses
The left lung of animals was used for the determination of total protein content by the Bradford's method (1976) and inflammation and oxidative stress analyses. The right lung and the liver of each animal were isolated for cylindrospermopsin content analysis by enzyme-linked immunosorbent assay (ELISA). Briefly, the tissues were homogenized in buffer solution (0.1 g of tissue/mL) containing EDTA (0.1 mM), DTT (1 mM), Tris-HCl, pH 7.0 (50 mM) and the protease inhibitor phenylmethylsulphonyl fluoride (0.1 mM), at 4 C, using a Tissuemiser homogenizer (Fisher Scientific, Hampton, NH, USA). The resultant homogenates were centrifuged (10,000 Â g) and the supernatants were stored in glass vials at À20 C until the analyses were done.
Myeloperoxidase (MPO)
Inflammatory changes were examined by MPO activity in the supernatant of lung homogenates. Absorbances were determined at 655 nm using a plate reader (Model 550, BioRad, Hercules, CA, USA) (Suzuki et al., 1983) . Myeloperoxidase activity was expressed in mU/mg protein.
Lipid peroxidation, superoxide dismutase (SOD) and catalase (CAT) activities
The thiobarbituric acid-reactive substances (TBARS) method analyzed malondialdehyde (MDA) products during an acid-heating reaction (Draper and Hadley, 1990) . MDA levels were determined at 532 nm and expressed as nmol/mg protein. SOD activity was assayed by measuring inhibition of adrenaline auto-oxidation as absorbance at 480 nm and was expressed as SOD equivalents (U/mg protein) (Bannister and Calabrese, 1987) . CAT activity was measured by the rate of decrease in hydrogen peroxide concentration at 240 nm and was expressed as CAT equivalents (U/mg protein) (Aebi, 1984) . A spectrophotometer was used in all determinations (Ultrospec 2100 pro, Amersham-Biosciences, Buckinghamshire, UK).
Cylindrospermopsin determination in tissues
Cylindrospermopsin was detected in lung and liver homogenate supernatants by ELISA commercial kits (Beacon Analytical Systems, Portland, ME, USA) according to the manufacturer's instructions. The limit of quantification of this method corresponds to 0.1 ng/m. Final values were expressed as ng of cylindrospermopsin/g of pulmonary or hepatic tissue.
Statistical analysis
SigmaStat 3.11 statistical software package (SYSTAT, Chicago, IL, USA) was used. The normality of the data (Kolmogorov-Smirnov test with Lilliefors' correction) and the homogeneity of variances (Levene median test) were tested. If both conditions were satisfied, one-way ANOVA was used, followed by Bonferroni's test for multiple comparisons when needed. If one or both conditions was not satisfied Kruskal-Wallis ANOVA was used followed by a Dunn's test. In all instances the significance level was set at 5% (p < 0.05).
Results
Pulmonary mechanics
A single sublethal dose of cylindrospermopsin significantly increased Est at 24 and 48 h after intratracheal instillation; DE and DP2 were higher than SAL at 24 h after exposure to cylindrospermopsin. DP1 and DPtot did not differ among groups (Fig. 1). Fig. 2 shows photomicrographs of lung parenchyma in SAL and CYN groups. Table 1 depicts the fraction area of alveolar collapse and the content of polymorpho-(PMN) and mononuclear (MN) cells in pulmonary parenchyma. Exposure to cylindrospermopsin increased the fraction area of collapse and PMN influx into the lung parenchyma compared with SAL. The increase in alveolar collapse started at 8 h, reaching a maximum at 48 h, diminished at 96 h, but did not return to SAL values. A higher amount of PMN/ mm 2 was observed from 24 until 96 h. On the other hand, a decrease in the MN cell content was found in all CYN groups in relation to SAL (Table 1 and Fig. 2 ). Fig. 3 depicts MPO, SOD and CAT activities and MDA levels in lung homogenates of SAL and CYN groups. There was a significant increase in MPO activity from 24 to 96 h, reaching a peak at 48 h after CYN exposure. SOD activity was significantly higher at 2 and 8 h, progressively returning to SAL values at 96 h. There was a significant decrease in CAT activity at 48 and 96 h, as compared with SAL. MDA levels increased significantly from 8 until 48 h after exposure to cylindrospermopsin. Fig. 4 presents cylindrospermopsin concentrations in the liver and lung cytosols. There was a higher amount of cylindrospermopsin in the lung at the first 24 h after intratracheal instillation and in the liver the concentration increased significantly at 96 h after intratracheal instillation.
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Discussion
Our results demonstrated that a single sub-lethal dose of cylindrospermopsin intratracheally administered impaired in vivo pulmonary function, characterized by increased elastic and viscoelastic components of lung mechanics. Exposure to cylindrospermopsin also induced damage to pulmonary parenchyma as indicated by the increased amount of alveolar collapse, PMN influx, and oxidative stress. In the lungs the toxin concentration decreased and in the liver it increased as a function of time.
In the present study we used a sub-lethal dose (0.07 mg/ kg) of cylindrospermopsin once human and animal exposures to non-lethal concentrations are more common than acute intoxications. Indeed, no death occurred during the experiments. The literature shows that LD 50 of this toxin presents a toxicity that varies in the time of death according to the intraperitoneal dose in mice: 2.0 mg/kg BW causes death in 24 h and 0.2 mg/kg BW along 5-6 days (Norris et al., 2002) . Hence, this may suggest its slow and progressive process of poisoning in the face of sub-lethal doses. In fact, animal and human exposures to these doses occur more frequently than lethal events, damaging many organs, such as liver, kidneys, thymus, heart and lung (Falconer et al., 1999; Humpage and Falconer, 2003; Pegram et al., 2007) .
We could detect a higher concentration of cylindrospermopsin in the lung along the first 24 h after intratracheal instillation (Fig. 4) , possibly due to the direct pathway of the toxin. Furthermore, we observed that the concentration in the liver increased significantly at 96 h after instillation. Since cylindrospermopsin was administered by the intratracheal route, it rapidly reached the lung, then going to the target organs, such as liver and kidneys. Considering that the kinetics of cylindrospermopsin and its metabolites in the liver, and mainly in other organs and bloodstream, is poorly understood, the present work does not provide a proven explanation for the increase in the toxin concentration in the liver at 96 h after intoxication.
The kidneys seem to be the most sensitive organs in mice exposed sub-chronically to cylindrospermopsin , while the liver plays a key role in the metabolism of that toxin, with the involvement of cytochrome P450 (CYP450) enzymatic system. Froscio et al. (2003) observed protection from cylindrospermopsin toxicity by CYP450 inhibitors; thus it is possible that the early and higher toxicity is related to CYP450-dependent activation, once more toxic cylindrospermopsin metabolites can spread by the bloodstream (Norris et al., 2001) . Indeed, these authors reported the presence of the toxin's metabolites in the liver and kidney tissues of mice exposed intraperitoneally to radiolabelled cylindrospermopsin. According to Bryant and Knights (2010) , the parent cylindrospermopsin can also enter the bloodstream and reach other organs. Unfortunately, there is no information in the literature concerning the bloodstream transport of cylindrospermopsin metabolites. The later toxicity would be a consequence of protein synthesis inhibition (Runnegar et al., 2002) . Reactive oxygen species (ROS) can yield lung injury by means of several mechanisms, including lipid peroxidation with formation of pro-inflammatory molecules such as thromboxane, oxidation of proteins that leads to the release of proteases and inactivation of antioxidant and proteaseinhibiting enzymes, and also alteration of the expression of transcription factors such as nuclear factor (NF)-kB, which generates an enhanced expression of pro-inflammatory genes (Fialkow et al., 1994; Chow et al., 2003) . There is evidence that intoxication with cyanotoxins may lead to oxidative stress and lesion in some organs, such as liver, kidney and lungs (Moreno et al., 2005; Carvalho et al., 2010) . In mice liver there are also reports of cylindrospermopsininduced depletion of glutathione, a tripeptide that plays an important role in the detoxification of many xenobiotics and participates in cellular defense against oxidative damage (Runnegar et al., 1994; Humpage et al., 2005) . In the present study, the latter could also contribute to the toxicity induced by cylindrospermopsin, once depleted glutathione content would result in a less important removal of reactive oxygen species. Generally, as a result of initial oxidative stress, there is an activation of the antioxidant defense system in order to minimize the tissue damage. In this line, we analyzed antioxidant enzymes involved in the balance of redox status (SOD and CAT) as well as a marker of oxidative damage (lipid peroxidation) in samples of lung tissue of mice (Fig. 3) . SOD catalyzes superoxide anion dismutation to molecular oxygen and hydrogen peroxide. The latter is detoxified by CAT activity and both enzymes can be triggered after a poisoning event with microcystins (Pandey et al., 2003) . The present study identified a crescent increase in SOD activity until 8 h after exposure to cylindrospermopsin, thus confirming that the native toxin could increase superoxide anion production. SOD activity was reduced after the initial effect until returning to control levels in 96 h, in line with the notion that SOD is the first defense line against ROS (Foronjy et al., 2006) . Additionally, SOD activity could have diminished as a consequence of the decreasing amount of toxin in the lung as time progressed (Fig. 4) .
On the other hand, CAT activity was similar to control until 24 h after cylindrospermopsin exposure and significantly decreased afterwards. These data corroborate those aforementioned. Since CAT takes part in catalyzing hydrogen peroxide, its performance depends on SOD substrate, i.e., hydrogen peroxide. Moreover, the reduction in CAT activity in CYN48 and CYN96 is in agreement with the increase in MPO in these groups (Fig. 3) . MPO also uses hydrogen peroxide as a substrate, whose affinity is higher for MPO than for CAT. Hydrogen peroxide is a stable ROS, so in inflammatory conditions such as increased PMN influx it could react more with MPO after 24 h, leading to the production of another ROS, the hypochlorous acid, which also contributes to oxidative stress.
Lipid peroxidation is a cascade of events which can generate lipid subproducts that can be measured to quantify oxidative damage (Jayaraj et al., 2006; Weng et al., 2007) . There are no studies relating cylindrospermopsin exposure to oxidative stress in the lung. Our study describes a statistically significant increase in lipid peroxidation from 8 to 48 h after exposure to the toxin, with return to control parameters in 96 h (Fig. 3) . Therefore, we can state that oxidative damage took place in mice lungs as a consequence of antioxidant imbalance generated by cylindrospermopsin. Thus, we believe that this effect could increase the fraction areas of alveolar collapse from 8 h on and also possibly yielded the recruitment of inflammatory cells into the lung parenchyma, indicated by the increase in myeloperoxidase activity and polymorphonuclear cells from 24 h on after exposure to the toxin (Fig. 2, Table 1 ).
Despite the main hepatic and renal effects, two studies showed that the lungs can also be affected by exposure to cylindrospermopsin (Hawkins et al., 1985; Bernard et al., 2003) . These authors reported that mice intraperitoneally injected with lethal doses of this toxin showed signals of congestion and hemorrhage in the lungs. Indeed, our histopathological study revealed changes in pulmonary parenchyma, evidenced by discrete edema, thickening of alveolar septa and collapsed areas in CYN groups (Fig. 2,  Table 1 ). However, we did not observe intra-alveolar hemorrhage certainly due to the sub-lethal dose administered. Lungs may have been damaged by ROS production derived from native cylindrospermopsin and its metabolites or by activated defense cells along the inflammatory process, which could explain the increase in alveolar collapsed areas after 24 h in our mice injected with the toxin (Fig. 2, Table 1 ).
As a result of lung inflammation, oxidative stress and lesion, pulmonary mechanics became impaired as a consequence of stiffer lungs, indicated by lung static elastance (Est) and viscoelastic components (DE and DP2, Fig. 1 ) at 48 h after exposure. Even though cylindrospermopsin was intratracheally administered, it triggered lung mechanical alterations later than microcystin-LR by intra-peritoneal injection (Soares et al., 2007; Carvalho et al., 2010; Casquilho et al., 2011) . Another difference was that these authors also found an increase in the pressure spent to overcome central airway resistance which was not produced by cylindrospermopsin.
Finally, based on our results and on the literature, we might hypothesize two patterns of effects in the lungs after cylindrospermopsin exposure. The former would be related to the direct route by which the toxin reaches the lung and possibly ellicits its early effects, such as oxidative stress through ROS production. The second one is characterized by pulmonary inflammatory response and functional changes, possibly induced by the action of early produced ROS and protein synthesis inhibition.
Our study presents limitations: (1) its design does not allow gathering information on the dose-response profile of the lesions; (2) we chose the intratracheal instillation to guarantee that the administered toxin would reach the lung, thus avoiding its eventual swallowing. The latter could occur if the intranasal (i.n.) route were used. Human beings are not expected to be contaminated by the intratracheal route; and, (3) It was not possible to calculate the mass balance of cylindrospermopsin in the tissues, and thus we cannot warrant that the detected values represent the total concentrations of the toxin in the tissues, i.e., maybe ELISA could not detect cylindrospermopsin attached to other cellular organelles, such as ribosomes and/or other translational components (Froscio et al., 2008) .
Conclusion
We conclude that the aggression of sub-lethal concentration of cylindrospermopsin to otherwise healthy mice impaired lung mechanics, which was preceded by lung parenchyma inflammation and oxidative stress.
